MSU
COCH icon

Mizuho Securities USA’s Envoy Medical COCH Stock Holding History

Mizuho Securities USA’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-241,401
Closed -$2.44M – 227
2023
Q2 		$2.44M Buy
+241,401
New +$2.44M 0.08% 99

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Mizuho Securities USA's COCH Position: Q3 2023 in Review

Mizuho Securities USA sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 241,401 shares — an estimated $2.44M sold.

Mizuho Securities USA first reported a position in COCH in Q2 2023 and held it in 1 quarter. The position peaked at $2.44M in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

  • Mizuho Securities USA reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
  • Mizuho Securities USA sold 241,401 Envoy Medical shares in Q3 2023, an estimated $2.44M.
  • Mizuho Securities USA first reported a position in Envoy Medical in Q2 2023 and held it in 1 quarter.
  • Mizuho Securities USA's Envoy Medical position peaked at $2.44M in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on Mizuho Securities USA's 13F filing for Q3 2023, filed 9 Nov 2023.